UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

Primary cutaneous Hodgkin lymphoma

Journal of the American Academy of Dermatology, 2010-08, Vol.63 (2), p.e52-e53

2010

Volltextzugriff (PDF)

Breast Implant–Associated Anaplastic Large Cell Lymphoma: Proposal for a Monitoring Protocol

Plastic and reconstructive surgery (1963), 2015-08, Vol.136 (2), p.144e-151e

2015

Volltextzugriff (PDF)

The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study

Leukemia & lymphoma, 2017-01, Vol.58 (1), p.226-229

2017

Volltextzugriff (PDF)

Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practice

Leukemia & lymphoma, 2015-06, Vol.56 (6), p.1671-1676

2015

Volltextzugriff (PDF)

Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma

Journal of neuro-oncology, 2007-01, Vol.81 (2), p.197-199

2007

Volltextzugriff (PDF)

Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90 Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM

Journal of clinical oncology, 2013-08, Vol.31 (23), p.2974-2976

2013

Volltextzugriff (PDF)

Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM

Journal of clinical oncology, 2013-08, Vol.31 (23), p.2974-2976

2013

Volltextzugriff (PDF)

Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors

Transfusion and apheresis science, 2002-04, Vol.26 (2), p.103-110

2002

Volltextzugriff (PDF)

Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation

The hematology journal : the official journal of the European Haematology Association, 2004, Vol.5 (1), p.24

2004

Volltextzugriff (PDF)

Erythema Annulare Centrifugum Associated with Mantle B-cell Non-Hodgkin's Lymphoma

Acta dermato-venereologica, 2009, Vol.89 (3), p.319-320

2009

Volltextzugriff (PDF)

CD4+/CD56+ hematodermic neoplasm

EJD. European journal of dermatology, 2011-03, Vol.21 (2), p.291-292

2011

Volltextzugriff (PDF)

Differentiation on Biological Basis of Monoclonal B-Cell Lymphocytosis (MBL) From Chronic Lymphocytic Leukemia (CLL): Results of a Prospective GISL (Gruppo Italiano Studio Linfomi) Trial

Blood, 2010-11, Vol.116 (21), p.1360-1360

2010

Volltextzugriff (PDF)

Analysis of Stereotyped IGHV Distribution In a Series of 1133 Chronic Lymphocytic Leukemia Patients: The Experience of a Multicenter Italian Study Group

Blood, 2010-11, Vol.116 (21), p.2423-2423

2010

Volltextzugriff (PDF)

Incidence of Cytogenetic Abnormalities In Newly Diagnosed Binet Stage A CLL and Relationship with Prognostic Biomarkers and with Stereotyped B Cell Receptors: Updated Results on 344 Patients Included In the Prospective O-CLL1 GISL Study

Blood, 2010-11, Vol.116 (21), p.4613-4613

2010

Volltextzugriff (PDF)

External Validation On Biological Basis of New Prognostic Index in Early Asymptomatic Chronic Lymphocytic Leukemia (CLL) Patients: The Gruppo Italiano Studio Linfomi (GISL) Experience

Blood, 2009-11, Vol.114 (22), p.2375-2375

2009

Volltextzugriff (PDF)

Incidence of Cytogenetic Abnormalities in Newly Diagnosed Binet Stage A B-CLL and Relationship with Prognostic Biomarkers: Preliminary Results On 305 Patients Included in the Prospective O-CLL1 GISL Study

Blood, 2009-11, Vol.114 (22), p.2341-2341

2009

Volltextzugriff (PDF)

Clinical Relevance of P-Glycoprotein Expression in De Novo Acute Myeloid Leukemia

Blood, 1996-03, Vol.87 (5), p.1997-2004

1996

Volltextzugriff (PDF)

Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia

Blood, 1996-03, Vol.87 (5), p.1997-2004

1996

Volltextzugriff (PDF)

P-Glycoprotein Expression in De Novo Acute Myeloid Leukemia

Leukemia & lymphoma, 1997, Vol.27 (3-4), p.257-274

1997

Volltextzugriff (PDF)

CD4(+)/CD56(+) hematodermic neoplasm

European journal of dermatology : EJD, 2011, Vol.21 (2), p.291-292

2011

Volltextzugriff (PDF)

Primary cutaneous Hodgkin lymphoma

Journal of the American Academy of Dermatology, 2010, Vol.63 (2), p.e52-e53

2010

Volltextzugriff (PDF)

Erythema annulare centrifugum associated with mantle b-cell non-Hodgkin's lymphoma

Acta dermato-venereologica, 2009, Vol.89 (3), p.319-320

2009

Volltextzugriff (PDF)

Ten simple rules for making a vocabulary FAIR

PLoS computational biology, 2021-06, Vol.17 (6), p.e1009041-e1009041

2021

Volltextzugriff (PDF)

Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial

The Lancet (British edition), 2015-06, Vol.385 (9985), p.2355-2362

2015

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(72)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Primary cutaneous Hodgkin lymphoma

Breast Implant–Associated Anaplastic Large Cell Lymphoma: Proposal for a Monitoring Protocol

The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study

Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practice

Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma

Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90 Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM

Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM

Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors

Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation

Erythema Annulare Centrifugum Associated with Mantle B-cell Non-Hodgkin's Lymphoma

CD4+/CD56+ hematodermic neoplasm

Differentiation on Biological Basis of Monoclonal B-Cell Lymphocytosis (MBL) From Chronic Lymphocytic Leukemia (CLL): Results of a Prospective GISL (Gruppo Italiano Studio Linfomi) Trial

Analysis of Stereotyped IGHV Distribution In a Series of 1133 Chronic Lymphocytic Leukemia Patients: The Experience of a Multicenter Italian Study Group

Incidence of Cytogenetic Abnormalities In Newly Diagnosed Binet Stage A CLL and Relationship with Prognostic Biomarkers and with Stereotyped B Cell Receptors: Updated Results on 344 Patients Included In the Prospective O-CLL1 GISL Study

External Validation On Biological Basis of New Prognostic Index in Early Asymptomatic Chronic Lymphocytic Leukemia (CLL) Patients: The Gruppo Italiano Studio Linfomi (GISL) Experience

Incidence of Cytogenetic Abnormalities in Newly Diagnosed Binet Stage A B-CLL and Relationship with Prognostic Biomarkers: Preliminary Results On 305 Patients Included in the Prospective O-CLL1 GISL Study

Clinical Relevance of P-Glycoprotein Expression in De Novo Acute Myeloid Leukemia

Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia

P-Glycoprotein Expression in De Novo Acute Myeloid Leukemia

CD4(+)/CD56(+) hematodermic neoplasm

Primary cutaneous Hodgkin lymphoma

Erythema annulare centrifugum associated with mantle b-cell non-Hodgkin's lymphoma

Ten simple rules for making a vocabulary FAIR

Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study

Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial

Suchergebnisse filtern